Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

MacKenzie Patterson

Physician Assistant, Surgical Stamford, CT Physician Assistant

NPI 1235686098 CMS profile 10836912

1 Blachley Rd, Stamford, CT 06902

Open in the dashboard

General payments

$6,667

76 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, MacKenzie Patterson of Stamford, CT is reported in the CMS Open Payments database as having received $6,667 across 76 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,275 20
2024 General $2,128 32
2023 General $2,118 22
2021 General $146 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • MacKenzie Patterson
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to MacKenzie Patterson were reported at $2,275. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year MacKenzie Patterson Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $146 $111 $36–$285 $132
2022 $0 $126 $44–$350 $149
2023 $2,118 $137 $47–$355 $160
2024 $2,128 $146 $49–$384 $164
2025 $2,275 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Arthrex, Inc. $3,458 43 payments
  2. Polaris Technology Solutions LLC $1,950 15 payments
  3. DePuy Synthes Sales Inc. $754 9 payments
  4. Bioventus LLC $270 7 payments
  5. Stryker Corporation $235 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Travel and Lodging $3,650 12 payments
  2. Food and Beverage $3,017 64 payments
Products named General payments · program years 2021–2025
  1. TWISTR $608 5 payments
  2. MILAGRO $608 5 payments
  3. RIGIDLOOP $468 4 payments
  4. HEALIX KNOTLESS PEEK $368 4 payments
  5. VAPR $271 2 payments
  6. DYNACORD $227 2 payments
  7. DUROLANE $223 5 payments
  8. MAKO $141 1 payment
  9. N/A $140 1 payment
  10. TRUESPAN ORTHOCORD $136 1 payment
  11. Other $540 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

38

Median for Physician Assistant: 241

Drug cost

$187

Median for Physician Assistant: $4,110

Branded share of claims

0%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 15 $158
Meloxicam Generic 23 $29

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Records

76 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record